Next Article in Journal
Short-Term Treatment with Alirocumab, Flow-Dependent Dilatation of the Brachial Artery and Use of Magnetic Resonance Diffusion Tensor Imaging to Evaluate Vascular Structure: An Exploratory Pilot Study
Next Article in Special Issue
Extracellular Vesicles from Human Cerebrospinal Fluid Are Effectively Separated by Sepharose CL-6B—Comparison of Four Gravity-Flow Size Exclusion Chromatography Methods
Previous Article in Journal
Anorectal and Genital Mucosal Melanoma: Diagnostic Challenges, Current Knowledge and Therapeutic Opportunities of Rare Melanomas
Previous Article in Special Issue
Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma
 
 
Review
Peer-Review Record

Dynamic Intercell Communication between Glioblastoma and Microenvironment through Extracellular Vesicles

Biomedicines 2022, 10(1), 151; https://doi.org/10.3390/biomedicines10010151
by Gloria Krapež, Katarina Kouter, Ivana Jovčevska * and Alja Videtič Paska *
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Biomedicines 2022, 10(1), 151; https://doi.org/10.3390/biomedicines10010151
Submission received: 10 December 2021 / Revised: 5 January 2022 / Accepted: 9 January 2022 / Published: 11 January 2022

Round 1

Reviewer 1 Report

The manuscript is well written, it sums up various aspects about extracellular communication between glioblastoma cells and neighboring cells in the TME, as well as some systemic effects mediated by EVs.

The modulation of M1 macrophages to M2-TAM is a very interesting mechanism commonly shared with other malignancies (i.e. PCs), and it is mentioned the role of the PD-L1 expression in that specific context regarding to macrophages. Although there are evidences of PD-L1 expression on glioblastoma-derived EVs (which are enriched upon stimulation of glioblastoma cells with pro-inflammatory cytokines), with the potential to directly bind to PD1 on the surface of T-cells. This mechanism has been shown to be capable of T-cell modulation of T-cells tumor-suppressing activity according to Ricklef et al (2018 manuscript). It would be nice to add those informations in the current review for overall completion even without pushing too far into the lymphocytes topic.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

The manuscript reviews the genetic composition of glioblastoma and its microenvironment, in which vesicles (EVs) mediate interaction between tumor cells and stroma cells as well as immune suppression. Moreover, EV roles in inflammation and its therapeutic application are discussed.

1.EV type (exosomes, micro vesicles, etc) and content classification and their roles (protein, microRNA, mRNA, etc) need to be elaborated in more details.

  1. In addition to glioblastoma cells, the other cell types in the microenvironment contribute to EVs production that has been shown in some papers. This is good to be included for discussion.
  2. Are there more recent research using EVs for targeting delivery and some clinical trials ongoing? This information is helpful to support the potential of EVs application to therapy.
  3. The tumor cells and immune cells, etc need to be added to the Figure 1 schema.
  4. The number of glioma cells needs to be given for producing 10,000 EVs over the period of 48 hours on line 33 of page 3.
  5. Some grammar error and typo: line 12 on page 7 – a space should be given between the sentences; line 17 on page 8 – “that” should be “than’; line 23 on page 23 – inconsistency with past tense in the previous sections.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop